Another successful milestone completed!
$Clovis Oncology(CLVS.US$ https://www.businesswire.com/news/home/20220331005384/en/Clovis-Oncology%E2%80%99s-Rubraca%C2%AE-Rucaparib-Significantly-Improves-Progression-Free-Survival-in-First-line-Maintenance-Treatment-in-Women-with-Ovarian-Cancer-Regardless-of-Their-Biomarker-Status-in-Phase-3-ATHENA-MONO-Trial
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
maachaadooOP : CLVS stock closed at $2.96 and is up $0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CLVS has a roughly average overall score of 49 meaning the stock holds a better value than 49% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. CLVS gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral.